HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neutrophil Infiltration and Acinar-ductal Metaplasia Are the Main Pathological Findings in Pembrolizumab-induced Pancreatitis.

Abstract
The histopathological findings of immune checkpoint inhibitor (ICI)-induced pancreatitis have rarely been reported. A 56-year-old man with squamous cell carcinoma of the lung with bone metastasis was being treated with pembrolizumab, an anti-programmed cell death protein-1 antibody. After 13 doses, he was referred to our department due to pancreatitis. Despite characteristic symptoms of acute pancreatitis, imaging findings were similar to those of autoimmune pancreatitis. However, a histological examination showed neutrophil-based inflammatory cell infiltration and acinar-ductal metaplasia. Immunostaining showed CD8-positive T lymphocyte infiltration. This case revealed the characteristic histopathology of pembrolizumab-induced pancreatitis, which was previously poorly understood.
AuthorsMorihisa Hirota, Keigo Murakami, Akinobu Koiwai, Keita Kawamura, Yuki Yoshino, Atsuko Takasu, Ryo Kin, Tomofumi Katayama, Katsuya Endo, Takayuki Kogure, Takayoshi Meguro, Toshiharu Tabata, Kazuhiro Murakami, Kennichi Satoh
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 61 Issue 24 Pg. 3675-3682 (Dec 15 2022) ISSN: 1349-7235 [Electronic] Japan
PMID35527030 (Publication Type: Case Reports, Journal Article)
Chemical References
  • pembrolizumab
Topics
  • Male
  • Humans
  • Middle Aged
  • Pancreatitis (chemically induced, pathology)
  • Neutrophil Infiltration
  • Acute Disease
  • Metaplasia (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: